These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 16339670

  • 1. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

  • 2. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ, Nienhuis AW.
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM, Pace B.
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [Abstract] [Full Text] [Related]

  • 4. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ, Charache S, Nora R, Boyer SH.
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract] [Full Text] [Related]

  • 16. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Approaches to the reactivation of hemoglobin F as a treatment for sickle cell disease.
    DeSimone J.
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):23-4. PubMed ID: 16163154
    [No Abstract] [Full Text] [Related]

  • 20. Gene switching -- a new therapeutic epoch: discussion paper.
    Nalbandian RM, Cypress GC.
    J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.